Listen to Geoff’s narration of this blog This is a wrenching, disturbing blog. It’s putatively about the war on cancer, but it’s really about medicine and all the weirdnesses that goes into fighting a disease. You might think that in cancer...
The NIH’s RECOVER Initiative is in a strange place. It’s gone through most of its $1.15 billion nest egg without producing anything of note and its critics abound. It does have its supporters. Steven Deek at UCSF called RECOVER “a great success“, and...
Recovering RECOVER? They had to do something. With the money running out next year, the NIH and its RECOVER Initiative were looking at pulling the plug on over 80 clinics and kissing the $1.15 billion Congress had invested in the program goodbye – all the while...
An Interesting Time for ME/CFS at the NIH National Institutes of Health (NIH) Conferences on ME/CFS are rare events – the last one was four years ago. They’re important in several ways – for one, because they have the imprimatur of the NIH,...
Anthony Fauci’s take on ME/CFS, long COVID, and other post-infectious diseases provides an informative counterpoint to Phillips and Williams’s stunning proposition that federal funders “prioritize care delivery over research” – thus...
Eric Topol Decorated researcher, fierce critic, and innovator Eric Topol is not one to hide his light under a bushel. He speaks his mind. Whether he’s right or wrong, with the kind of bona fides Topol brings to the game (he founded the Scripps Research...